Growth Metrics

Inmune Bio (INMB) Receivables - Other (2021 - 2025)

Historic Receivables - Other for Inmune Bio (INMB) over the last 5 years, with Q3 2025 value amounting to $760000.0.

  • Inmune Bio's Receivables - Other rose 3944.95% to $760000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $760000.0, marking a year-over-year increase of 3944.95%. This contributed to the annual value of $228000.0 for FY2024, which is 5754.19% down from last year.
  • As of Q3 2025, Inmune Bio's Receivables - Other stood at $760000.0, which was up 3944.95% from $550000.0 recorded in Q2 2025.
  • In the past 5 years, Inmune Bio's Receivables - Other registered a high of $760000.0 during Q3 2025, and its lowest value of $100000.0 during Q3 2022.
  • Moreover, its 5-year median value for Receivables - Other was $362000.0 (2022), whereas its average is $389384.6.
  • Per our database at Business Quant, Inmune Bio's Receivables - Other skyrocketed by 4834.25% in 2023 and then crashed by 7612.21% in 2025.
  • Over the past 5 years, Inmune Bio's Receivables - Other (Quarter) stood at $300000.0 in 2021, then increased by 20.67% to $362000.0 in 2022, then surged by 48.34% to $537000.0 in 2023, then tumbled by 57.54% to $228000.0 in 2024, then skyrocketed by 233.33% to $760000.0 in 2025.
  • Its Receivables - Other was $760000.0 in Q3 2025, compared to $550000.0 in Q2 2025 and $133000.0 in Q1 2025.